CHRM1 and pancreatic neoplasm: Interestingly, recent data from Renz et al. demonstrate that disruption of ACh signaling by vagotomy or muscarinic ACh receptor 1 (Chrm1) ablation accelerated tumorigenesis in experimental pancreatic cancer [37].